Stone Crest Wealth Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Stone Crest Wealth Management, Inc.
- $131 Billion
- Q2 2024
A detailed history of Stone Crest Wealth Management, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Stone Crest Wealth Management, Inc. holds 316 shares of REGN stock, worth $332,191. This represents 0.25% of its overall portfolio holdings.
Number of Shares
316
Previous 321
1.56%
Holding current value
$332,191
Previous $309 Million
7.5%
% of portfolio
0.25%
Previous 0.27%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,463Shares Held
84.5MCall Options Held
907KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$9.45 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$8.88 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$8.7 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$5.09 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$4.88 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $113B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...